Person:
ERGÖR, SERAP NUR

Loading...
Profile Picture
Status
Kurumdan Ayrılmıştır
Organizational Units
Organizational Unit
Job Title
First Name
SERAP NUR
Last Name
ERGÖR
Name
Email Address
Birth Date

Search Results

Now showing 1 - 6 of 6
  • PublicationOpen Access
    Co-occurrence of interrupted aortic arch and Apert syndrome: A case report.
    (2021-01-01T00:00:00Z) Ergor, SERAP NUR; Duman, Nilgun; Kutuk, Mehmet Serdar; Yozgat, Can Yilmaz; Temur, Hafize Otcu; Ugurlucan, Murat; Yozgat, Yilmaz; ERGÖR, SERAP NUR; DUMAN, NİLGÜN; YOZGAT, YILMAZ
  • PublicationMetadata only
    Reference ranges of presepsin (soluble CD14 subtype) in term and preterm neonates without infection, in relation to gestational and postnatal age, in the first 28 days of life
    (2020-03-01T00:00:00Z) Ergor, SERAP NUR; YALAZ, MEHMET; ALTUN KÖROĞLU, ÖZGE; YILDIRIM SÖZMEN, ESER; AKISÜ, METE; KÜLTÜRSAY, NİLGÜN; ERGÖR, SERAP NUR
    Objective: To determine the reference ranges of presepsin in term and preterm neonates without infection, with respect to gestational and postnatal age, within the first 28 days of life.
  • PublicationMetadata only
    Investigation of Congenital CMV Infection with the Presence of CMV DNA in Saliva Samples of New Born Babies
    (2019-01-01T00:00:00Z) Zeytinoglu, Aysin; TEREK, DEMET; Arslan, Ayse; Erensoy, Selda; ALTUN KÖROĞLU, ÖZGE; Bozdemir, Tugba; YALAZ, MEHMET; Ergor, SERAP NUR; ÖĞÜT, MEHMET FATİH; KÜLTÜRSAY, NİLGÜN; ERGÖR, SERAP NUR
    Cytomegalovirus (CMV), is the most common cause among congenital infections and is the most seen etiology in long-term sensorineural hearing loss (SNHL) and neurological impairment. Congenital CMV infection (CCMV) was reported in 0.15-2.2% of live-borne neonates in studies from different countries. A significant proportion of infected infants are asymptomatic after birth and might only be detected by routine screening methods during the new born period. The aim of this study was to screen the saliva of live-born neonates with areal-time PCR based method for the detection of CCMV in our hospital. Saliva samples collected in half an hour after birth by dry dacron swabs and were evaluated for CMV DNA (Rt-PCR, Abbott Molecular USA) from 1000 babies born in Ege University Faculty of Medicine Hospital Obstetrics Clinic between October 2015-October 2017. For the confirmation of CCMV, saliva positive newborns were evaluated with the same method for CMV DNA from their urine or blood within 21 days. All newborns were screened for sensorineural hearing tests. Subjects were 497 girls (49.7%) and 503 boys (50.3%), with a mean weight of 3116.8 g and mean of 37.61 birth week. CMV DNA was positive in the saliva of 16 newborns (1.6%). Fourteen newborns were weakly positive for CMV DNA in their saliva and were not confirmed for CCMV infection. Congenital CMV was confirmed in only two (0.2%) with the CMV DNA results in urine and/or blood samples. One of the two newborns with CCMV was symptomatic and had a neurosensorial hearing loss. The other one was asymptomatic. Saliva samples, taken immediately after birth with a noninvasive and easy method for the detection of CMV DNA is very important for diagnosis of CCMV. Positive samples should be confirmed with CMV DNA in urine or blood samples of these newborns. In this study, detection of positivity in saliva samples that were confirmed with other samples of our newborn population for CCMV was 0.2%. The specific diagnosis for CCMV in newborns with a noninvasive and easy collecting sample is important to avoid sequelae and for public health concerns.
  • PublicationMetadata only
    Short-term efficacy of ORS formulation and propranolol regimen in children with POTS
    (2020-08-01T00:00:00Z) YOZGAT, Yılmaz; OTÇU TEMUR, Hafize; Coban, Senay; Oner, Taliha; Karaarslan, Utku; Yozgat, Can Yilmaz; Karadeniz, Cem; ERGÖR, Serap Nur; ERENBERK, UFUK; YOZGAT, YILMAZ; OTÇU TEMUR, HAFİZE; ERGÖR, SERAP NUR; ERENBERK, UFUK
    Background: To evaluate the short-term effectiveness of reduced-osmolarity oral rehydration salt formulation (ORS) and propranolol in children diagnosed with postural orthostatic tachycardia syndrome (POTS) in head-up tilt testing (HUTT).
  • PublicationMetadata only
    Recurrent Elevation of Troponin Levels in Acute Myocarditis: Is it a Sign of Ventricular Tachycardia?
    (2020-07-01T00:00:00Z) Yozgat, Can Yilmaz; YEŞİLBAŞ, Osman; UZUNER, SELÇUK; SARITAŞ, BETÜL; ERGÖR, Serap Nur; OTÇU TEMUR, Hafize; YOZGAT, Yılmaz; YEŞİLBAŞ, OSMAN; UZUNER, SELÇUK; SARITAŞ, BETÜL; ERGÖR, SERAP NUR; OTÇU TEMUR, HAFİZE; YOZGAT, YILMAZ
  • PublicationMetadata only
    Development of Myocardial Infarction in a 12-Year-Old Female after the Use of Inhaled Salbutamol
    (2020-12-01T00:00:00Z) Yozgat, Can Yilmaz; UZUNER, SELÇUK; OTÇU TEMUR, Hafize; ERGÖR, Serap Nur; GULİYEVA, AYNUR; Tahaoglu, Irmak; Coban, Senay; YOZGAT, YILMAZ; UZUNER, SELÇUK; OTÇU TEMUR, HAFİZE; ERGÖR, SERAP NUR; GULİYEVA, AYNUR; YOZGAT, YILMAZ
    Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) accounts for 0.023% of all cases reported in pediatric patients. According to literature, only a handful of ALCAPA patients are able to reach adulthood. Clinical manifestations of ALCAPA range from fatigue during exercise to sudden death in adulthood. Herein, we described a 12-year-old symptomatic patient with ALCAPA who had severe chest pain after using salbutamol treatment for presumed asthma. ALCAPA is one of the curable versions of myocardial ischemia and infarction in childhood. Due to clinical findings in conjunction with electrocardiogram and echocardiography, a computed tomography scan with coronary angiography was performed and the diagnosis of ALCAPA was confirmed. We presented this case because ALCAPA-related myocardial ischemia and infarction in children are rare with only sporadic cases reported. This case illustrated the need for close monitoring and surgery as the best treatment for ALCAPA associated with myocardial infarction.